Faculty Opinions recommendation of Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
2014 ◽
Vol 13
(11)
◽
pp. 1100-1107
◽
2014 ◽
Vol 13
(9)
◽
pp. 885-892
◽